Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer

Multidrug resistance (MDR), mainly mediated by ABCB1 transporter, is a major cause for chemotherapy failure. Bufalin (BU), an active component of the traditional Chinese medicine chan’su, has been reported to have antitumor effects on various types of cancer cells. The purpose of this present study...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Yuan, Ze-Ting, Shi, Xiao-Jing, Yuan, Yu-Xia, Qiu, Yan-Yan, Zou, Yu, Liu, Cheng, Yu, Hui, He, Xue, Xu, Ke, Yin, Pei-Hao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564622/
https://ncbi.nlm.nih.gov/pubmed/28624793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18225
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak